Financial Ratios Patterson Companies, Inc.
Equities
PDCO
US7033951036
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.33 USD | +0.03% |
|
-.--% | - |
| 08/01 | Patterson Companies, Inc. Appoints Patrik Eriksson as North American President of Patterson Dental | CI |
| 22/25/22 | Patterson Companies, Inc. Announces Chief Executive Officer Changes | CI |
| Fiscal Period: April | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.89 | 4.89 | 4.47 | 6.31 | 5.77 | |||||
Return on Total Capital | 6.19 | 8.3 | 7.34 | 10.42 | 9.43 | |||||
Return On Equity % | -50.87 | 17.22 | 20.1 | 19.12 | 17.5 | |||||
Return on Common Equity | -50.92 | 17.36 | 20.27 | 19.23 | 17.55 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 21.81 | 20.35 | 19.83 | 21.22 | 21.01 | |||||
SG&A Margin | 18.42 | 16.73 | 16.81 | 16.83 | 16.95 | |||||
EBITDA Margin % | 4.89 | 4.95 | 4.28 | 5.68 | 5.4 | |||||
EBITA Margin % | 4.07 | 4.25 | 3.6 | 4.97 | 4.65 | |||||
EBIT Margin % | 3.39 | 3.62 | 3.02 | 4.38 | 4.06 | |||||
Income From Continuing Operations Margin % | -10.74 | 2.62 | 3.1 | 3.19 | 2.82 | |||||
Net Income Margin % | -10.72 | 2.64 | 3.13 | 3.21 | 2.83 | |||||
Net Avail. For Common Margin % | -10.72 | 2.64 | 3.13 | 3.21 | 2.83 | |||||
Normalized Net Income Margin | 1.45 | 2.13 | 1.95 | 2.59 | 2.32 | |||||
Levered Free Cash Flow Margin | 7.21 | 0.97 | 2.83 | 2.04 | 2.42 | |||||
Unlevered Free Cash Flow Margin | 7.74 | 1.22 | 2.88 | 2.26 | 2.73 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.83 | 2.16 | 2.37 | 2.3 | 2.27 | |||||
Fixed Assets Turnover | 15.95 | 17.4 | 22.39 | 21.97 | 20.01 | |||||
Receivables Turnover (Average Receivables) | 11 | 13.66 | 14.5 | 14 | 12.82 | |||||
Inventory Turnover (Average Inventory) | 5.46 | 6.08 | 6.84 | 6.45 | 6.58 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.44 | 1.48 | 1.65 | 1.64 | 1.33 | |||||
Quick Ratio | 0.57 | 0.71 | 0.78 | 0.8 | 0.65 | |||||
Operating Cash Flow to Current Liabilities | -0.23 | -0.67 | -0.97 | -0.7 | -0.59 | |||||
Days Sales Outstanding (Average Receivables) | 33.11 | 26.65 | 25.58 | 26 | 28.39 | |||||
Days Outstanding Inventory (Average Inventory) | 66.7 | 59.87 | 54.2 | 56.42 | 55.36 | |||||
Average Days Payable Outstanding | 63.29 | 57.79 | 45.52 | 50.11 | 51.7 | |||||
Cash Conversion Cycle (Average Days) | 36.52 | 28.73 | 34.26 | 32.32 | 32.05 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 82.27 | 76.03 | 57.59 | 57.33 | 77.51 | |||||
Total Debt / Total Capital | 45.14 | 43.19 | 36.55 | 36.44 | 43.66 | |||||
LT Debt/Equity | 77.79 | 56.36 | 51.97 | 47.53 | 43.38 | |||||
Long-Term Debt / Total Capital | 42.68 | 32.02 | 32.98 | 30.21 | 24.44 | |||||
Total Liabilities / Total Assets | 69.2 | 64.94 | 61.97 | 61.15 | 65.42 | |||||
EBIT / Interest Expense | 3.08 | 9.25 | 44.07 | 11.99 | 8.22 | |||||
EBITDA / Interest Expense | 5.04 | 14.16 | 70.49 | 17.03 | 12.12 | |||||
(EBITDA - Capex) / Interest Expense | 4.34 | 13.04 | 61.89 | 14.32 | 10.04 | |||||
Total Debt / EBITDA | 2.26 | 2.24 | 1.91 | 1.59 | 1.97 | |||||
Net Debt / EBITDA | 2 | 1.8 | 1.45 | 1.18 | 1.67 | |||||
Total Debt / (EBITDA - Capex) | 2.62 | 2.43 | 2.18 | 1.89 | 2.38 | |||||
Net Debt / (EBITDA - Capex) | 2.32 | 1.96 | 1.65 | 1.4 | 2.01 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -1.52 | 7.69 | 9.93 | -0.43 | 1.5 | |||||
Gross Profit, 1 Yr. Growth % | 0.56 | 0.48 | 7.14 | 6.51 | 0.53 | |||||
EBITDA, 1 Yr. Growth % | 4.66 | 9.14 | -4.99 | 32.07 | -3.41 | |||||
EBITA, 1 Yr. Growth % | 5.35 | 12.46 | -6.81 | 37.45 | -5.1 | |||||
EBIT, 1 Yr. Growth % | 7.23 | 14.94 | -8.27 | 44.6 | -5.99 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -811.14 | -126.32 | 30.05 | 2.42 | -10.2 | |||||
Net Income, 1 Yr. Growth % | -803.65 | -126.51 | 30.28 | 2.14 | -10.42 | |||||
Normalized Net Income, 1 Yr. Growth % | -2.64 | 57.59 | 0.75 | 32.17 | -9.1 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -802.25 | -125.76 | 27.95 | 2.91 | -6.6 | |||||
Accounts Receivable, 1 Yr. Growth % | -28.44 | 7.85 | -0.46 | 6.76 | 14.64 | |||||
Inventory, 1 Yr. Growth % | 6.72 | -9.29 | 6.63 | 1.21 | -1.53 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 25.17 | -22.49 | -4.31 | 7.53 | 15.12 | |||||
Total Assets, 1 Yr. Growth % | -16.94 | 1.33 | -0.36 | 5.02 | 0.61 | |||||
Tangible Book Value, 1 Yr. Growth % | 23.24 | 42.36 | 19.28 | 12.46 | -10.65 | |||||
Common Equity, 1 Yr. Growth % | -43.54 | 15.48 | 8.15 | 7.28 | -10.42 | |||||
Cash From Operations, 1 Yr. Growth % | -605.72 | 199.95 | 34.29 | -23.05 | 4.57 | |||||
Capital Expenditures, 1 Yr. Growth % | -31.16 | -38.32 | 48.55 | 67.64 | 5.3 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 6.04 | -85.48 | 220.31 | -28.44 | 20.67 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 6.19 | -83.06 | 159.8 | -21.59 | 22.33 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 0 | 0 | 0 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 0.22 | 2.98 | 8.81 | 4.62 | 0.53 | |||||
Gross Profit, 2 Yr. CAGR % | -0.08 | 0.52 | 3.76 | 6.82 | 3.48 | |||||
EBITDA, 2 Yr. CAGR % | -6 | 13.3 | 1.82 | 12.02 | 12.94 | |||||
EBITA, 2 Yr. CAGR % | -7.06 | 16.92 | 2.36 | 13.17 | 14.21 | |||||
EBIT, 2 Yr. CAGR % | -7.99 | 21.33 | 2.67 | 15.17 | 16.59 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 71.25 | 36.81 | -41.5 | 15.41 | -4.1 | |||||
Net Income, 2 Yr. CAGR % | 71.11 | 36.57 | -41.24 | 15.35 | -4.35 | |||||
Normalized Net Income, 2 Yr. CAGR % | -15.58 | 39.84 | 25.99 | 15.4 | 9.61 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 70.1 | 34.5 | -42.59 | 14.75 | -1.96 | |||||
Accounts Receivable, 2 Yr. CAGR % | -29.03 | -12.15 | 3.61 | 3.09 | 10.63 | |||||
Inventory, 2 Yr. CAGR % | 2.05 | -1.61 | -1.65 | 3.88 | -0.17 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 14.77 | -1.5 | -13.88 | 1.44 | 11.26 | |||||
Total Assets, 2 Yr. CAGR % | -11.56 | -8.26 | 0.48 | 2.29 | 2.79 | |||||
Tangible Book Value, 2 Yr. CAGR % | 22.04 | 32.45 | 30.31 | 15.82 | 0.24 | |||||
Common Equity, 2 Yr. CAGR % | -24.46 | -19.25 | 11.75 | 7.71 | -1.96 | |||||
Cash From Operations, 2 Yr. CAGR % | 16.68 | 289.48 | 100.7 | 1.65 | -10.3 | |||||
Capital Expenditures, 2 Yr. CAGR % | -1.69 | -34.84 | -4.28 | 57.81 | 32.87 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 52.68 | -59.8 | -31.8 | 51.4 | -7.08 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 46.08 | -56.62 | -33.66 | 42.73 | -2.06 | |||||
Dividend Per Share, 2 Yr. CAGR % | 0 | 0 | 0 | 0 | 0 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -0.62 | 2.65 | 5.25 | 5.64 | 3.57 | |||||
Gross Profit, 3 Yr. CAGR % | -2.74 | 0.1 | 2.68 | 4.67 | 4.68 | |||||
EBITDA, 3 Yr. CAGR % | -13.04 | -1.21 | 6.85 | 11.05 | 6.62 | |||||
EBITA, 3 Yr. CAGR % | -15.34 | -0.97 | 8.4 | 12.93 | 6.72 | |||||
EBIT, 3 Yr. CAGR % | -16.89 | -0.91 | 10.53 | 15.08 | 7.63 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 50.24 | -8.27 | 34.51 | -29.49 | 6.15 | |||||
Net Income, 3 Yr. CAGR % | 51.01 | -8.1 | 34.44 | -29.34 | 6.03 | |||||
Normalized Net Income, 3 Yr. CAGR % | -23.66 | 3.94 | 25.36 | 28.02 | 6.58 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 50.87 | -9.33 | 32.28 | -30.26 | 7.14 | |||||
Accounts Receivable, 3 Yr. CAGR % | -22.21 | -18.4 | -8.42 | 4.65 | 6.8 | |||||
Inventory, 3 Yr. CAGR % | 4.49 | -1.88 | 1.07 | -0.71 | 2.04 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 8.65 | 0.69 | -2.45 | -7.27 | 5.81 | |||||
Total Assets, 3 Yr. CAGR % | -8.18 | -7.46 | -5.7 | 1.97 | 1.73 | |||||
Tangible Book Value, 3 Yr. CAGR % | 34.93 | 28.47 | 27.91 | 24.06 | 6.22 | |||||
Common Equity, 3 Yr. CAGR % | -15.74 | -12.98 | -10.99 | 10.24 | 1.3 | |||||
Cash From Operations, 3 Yr. CAGR % | 14.39 | 59.84 | 173.11 | 45.8 | 2.62 | |||||
Capital Expenditures, 3 Yr. CAGR % | -3.84 | -15.84 | -14.24 | 15.38 | 37.9 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 32.45 | -30.31 | -19.71 | -30.7 | 40.37 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 29.12 | -28.77 | -21.22 | -29.86 | 35.58 | |||||
Dividend Per Share, 3 Yr. CAGR % | 2 | 0 | 0 | 0 | 0 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 7.02 | 1.88 | 3.05 | 3.44 | 3.34 | |||||
Gross Profit, 5 Yr. CAGR % | 2.46 | -1.88 | -0.19 | 2.74 | 3 | |||||
EBITDA, 5 Yr. CAGR % | -5.13 | -7.98 | -7.37 | 3.89 | 9.24 | |||||
EBITA, 5 Yr. CAGR % | -7.25 | -9.31 | -8.66 | 4.46 | 10.69 | |||||
EBIT, 5 Yr. CAGR % | -9.38 | -9.96 | -9.55 | 5.23 | 12.92 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 26.76 | -3.53 | 3.03 | 0.55 | 17.49 | |||||
Net Income, 5 Yr. CAGR % | 21.39 | -3.58 | 3.52 | 0.65 | 17.33 | |||||
Normalized Net Income, 5 Yr. CAGR % | -14.17 | -8.59 | -6.72 | 8.38 | 18.81 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 28.13 | -3.26 | 2.51 | -0.37 | 17.34 | |||||
Accounts Receivable, 5 Yr. CAGR % | -6.61 | -10.83 | -12.76 | -10.4 | -1.23 | |||||
Inventory, 5 Yr. CAGR % | 14.74 | 0.4 | 1.99 | 0.39 | 0.57 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 13.4 | 0.23 | -1 | 0.99 | 2.82 | |||||
Total Assets, 5 Yr. CAGR % | -1.61 | -4.81 | -4.81 | -3.67 | -2.39 | |||||
Tangible Book Value, 5 Yr. CAGR % | -18.91 | 36.23 | 33.06 | 23.25 | 16.02 | |||||
Common Equity, 5 Yr. CAGR % | -11.24 | -7.75 | -5.67 | -5.23 | -7.49 | |||||
Cash From Operations, 5 Yr. CAGR % | -1.5 | 36.12 | 43.23 | 33.37 | 74.95 | |||||
Capital Expenditures, 5 Yr. CAGR % | -7.17 | -20.13 | -4.02 | 8.22 | 2.17 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 20.72 | 44.01 | 1.56 | -4.95 | -14.87 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 19.34 | 15.22 | -1.08 | -5.94 | -14.05 | |||||
Dividend Per Share, 5 Yr. CAGR % | 4.87 | 2.93 | 1.2 | 0 | 0 |
- Stock Market
- Equities
- PDCO Stock
- Financials Patterson Companies, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















